Bank Of Hawaii Gilead Sciences, Inc. Transaction History

Bank Of Hawaii

$2.38 Billion
Q3 2024

A detailed history of Bank Of Hawaii transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bank Of Hawaii holds 8,985 shares of GILD stock, worth $820,779. This represents 0.03% of its overall portfolio holdings.

Number of Shares

8,985

Previous 10,147 11.45%

Holding current value

$820,779

Previous $696,000 8.19%

% of portfolio

0.03%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $77,377 - $97,596	-1,162 Reduced 11.45%	8,985 $753,000
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $53,298 - $61,510	-844 Reduced 7.68%	10,147 $696,000
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $42,876 - $52,286	-599 Reduced 5.17%	10,991 $805,000
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $109,685 - $124,385	-1,497 Reduced 11.44%	11,590 $938,000
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $1,996 - $2,178	27 Added 0.21%	13,087 $980,000
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $104,437 - $119,125	-1,374 Reduced 9.52%	13,060 $1.01 Million
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $516,817 - $588,814	-6,685 Reduced 31.65%	14,434 $1.2 Million
Q4 2022 Jan 30, 2023	SELL	$62.32 - $89.47 $372,798 - $535,209	-5,982 Reduced 22.07%	21,119 $1.81 Million
Q3 2022 Nov 09, 2022	SELL	$59.54 - $68.01 $15,659 - $17,886	-263 Reduced 0.96%	27,101 $1.67 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $23,145 - $26,069	-401 Reduced 1.44%	27,364 $1.69 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $33,072 - $41,443	-571 Reduced 2.02%	27,765 $1.65 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $32,050 - $36,378	494 Added 1.77%	28,336 $2.06 Million
Q3 2021 Nov 08, 2021	SELL	$67.69 - $73.03 $318,887 - $344,044	-4,711 Reduced 14.47%	27,842 $1.95 Million
Q2 2021 Jul 22, 2021	SELL	$63.47 - $69.35 $117,736 - $128,644	-1,855 Reduced 5.39%	32,553 $2.24 Million
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $94,200 - $107,482	-1,570 Reduced 4.36%	34,408 $2.22 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $30,137 - $34,340	-532 Reduced 1.46%	35,978 $2.1 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $6,706 - $8,432	108 Added 0.3%	36,510 $2.31 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $237,202 - $275,436	-3,279 Reduced 8.26%	36,402 $2.8 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $143,297 - $183,543	-2,288 Reduced 5.45%	39,681 $2.97 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $204,701 - $225,165	3,322 Added 8.6%	41,969 $2.73 Million
Q3 2019 Nov 15, 2019	SELL	$62.51 - $69.0 $182,404 - $201,342	-2,918 Reduced 7.02%	38,647 $2.45 Million
Q2 2019 Aug 15, 2019	BUY	$61.87 - $69.38 $235,910 - $264,545	3,813 Added 10.1%	41,565 $2.81 Million
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $1,438 - $1,611	-23 Reduced 0.06%	37,752 $2.46 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $3,571 - $4,661	59 Added 0.16%	37,775 $2.36 Million
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $40,772 - $45,142	-572 Reduced 1.49%	37,716 $2.91 Million
Q2 2018 Aug 06, 2018	SELL	$64.88 - $75.68 $178,420 - $208,120	-2,750 Reduced 6.7%	38,288 $2.71 Million
Q1 2018 May 04, 2018	SELL	$72.84 - $88.8 $97,896 - $119,347	-1,344 Reduced 3.17%	41,038 $3.09 Million
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $8,822 - $10,356	-124 Reduced 0.29%	42,382 $3.04 Million
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $600,171 - $711,366	8,323 Added 24.35%	42,506 $3.44 Million
Q2 2017 Aug 14, 2017	BUY	N/A	34,183	34,183 $2.42 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Hawaii, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Hawaii with notifications on news.

Account